Medexus Pharmaceuticals Inc. (TSX:MDP)

Canada · Delayed Price · Currency is CAD

3.940

+0.070 (1.81%)

Apr 10, 2026, 4:00 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Sales and Marketing Services in The Pharmaceutical Industry	108.33M	113.05M	108.10M	76.70M	79.66M
Sales and Marketing Services in The Pharmaceutical Industry Growth	-4.18%	4.59%	40.93%	-3.71%	43.52%
Total	108.33M	113.05M	108.10M	76.70M	79.66M
Total Growth	-4.18%	4.59%	40.93%	-3.71%	43.52%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
United States	68.61M	77.18M	78.94M	52.01M	60.37M
United States Growth	-11.10%	-2.23%	51.79%	-13.85%	72.20%
Canada	39.72M	35.87M	29.16M	24.70M	19.29M
Canada Growth	10.72%	23.03%	18.06%	28.00%	-5.65%
Total	108.33M	113.05M	108.10M	76.70M	79.66M
Total Growth	-4.18%	4.59%	40.93%	-3.71%	43.52%

Source: S&P Global Market Intelligence.